 |
|
|
| |
Daclatasvir in Combination With Sofosbuvir
With Or Without Ribavirin Is Safe and Efficacious in Liver Transplant Recipients With HCV Recurrence:
Interim Results of a European Multicenter Compassionate Use Program
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 17 San Francisco
Herzer K,1 Welzel TM,2 Ferenci P,3 Petersen J,4 Gschwantler M,5 Cornberg M,6 Berg T,7 Spengler U,8 Weiland O,9 Van der Valk M,10 Klinker H,11 Rockstroh J,8 Schott E,12 Peck-Radosavljevic M,3 Zhou Y,13 Jimenez-Exposito MJ,13 Zeuzem S2
1Universitatsklinikum Essen (AoR), Essen, Germany; 2Universitatsklinikum der Johann Wolfgang Goethe Universitat, Frankfurt, Germany; 3Medizinische Universitat Wien, Vienna, Austria; 4IFI Institut fur Interdisziplinare Medizin, Hamburg, Germany; 5Wilhelminenspital, Vienna, Austria; 6Medizinische Hochschule Hannover, Hannover, Germany; 7Universitatsklinikum Leipzig, Leipzig, Germany; 8Universitatsklinikum Bonn, Bonn, Germany; 9Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; 10Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; 11Universitatsklinikum Wurzburg, Wurzburg, Germany; 12Charité Universitatmedizin Berlin; Berlin, Germany; 13Bristol-Myers Squibb, Princeton, NJ, USA.
|
| |
|
|
|
|
|
